Member Info for MisterPositive

Oh dear....they get it wrong almost daily....then
Put an apology note, saying we got this one wrong

Yep. Some folks just take longer to accept that this share is now actually ready for a strong run.

NCYT languished for quite a while. It was @ 99p in just Feb 2020 and then BOOOMMMM...

NCYT had a strong run in 2020 hitting £12
GDR is poised for a repeat run of what NCYT did last year in my view. All signs are there.

There is going to be a shift with more investors coming into GDR during 2021.

If you got a good product to sell...then its makes the rest easy.

GDR got their break with Beckman Coulter deal and it was a BIG one. Others should follow. This deal alone is HUGE for Genedrive.

TESLA is your prime example.

Could GDR be our TESLA ?

In world of Investing...they say.

"Never too late to Buy a Good share"

If you done your research then no issues getting in. This is just the start.

Market is forward looking. Revenue numbers will soon start to stack up here and this should be in a much higher price bracket.

Reddit crew go 'Long' anyway to counter Shorters like Wall Street Hedge funds.

Bill
True. Amazing numbers.

No surprise when CEO said numbers will stack up pretty quickly.

Also lot lot more machines in USA which is home turf for 'Beckman Coulter'...

So your figures could also be at the low end...
If these are the low revenue estimates, then I cannot wait for Upper revenues range.

BigAl
Think you been bit conservative with your numbers....which is a good that.

£300m Mcap looks to be the lower range coming at £5 price.

But that would be a good start.

We can revise figures when other bigger players like Beckmam Coulter also sign up with GDR who got a niche...

GDR kits can detect ALL variants - old and New.

This is the Deal clincher.

I'm with you sir.

Pushing through all the way until delivered.
LoL

Whatever punter....

Still tiny no of shares in issue.

Russell.
Warrants...no issues. They will get churned and spat out within days when next few RNS land and we doing over 500m trading volume days.

Picked few more.

This price will look like a gift in a few weeks

1.20-1.30 could be here very quickly.

With only about 52m shares in issue this should rocket ahead as wider market takes notice.

Revenue numbers should increase substantially in coming weeks and months.

Beckman Coulter deal is just the start.

When a Multi-Billion $$$ company comes on board, other Big players in the industry follow.

More deals to follow.

£1 here today is a gonner....no issues.

GDR following similar trend.

In fact GDR could eclipse the £12 high at NCYT.

GDR will soon become the 'Go To' company after such strong endorsement from Beckman Coulter

That sir is a good dream.
You getting divine intervention.

Will add your results to the historical grades we know so far. Lot more to come.

Faré prospect, where historical drilling has returned best results of 20m grading 31.13 grammes per tonne ('g/t') gold ('Au') including 10m grading 60.98 g/t Au from reverse circulation ('RC') drilling and 59.60m grading 2.20 g/t Au and 49.50m grading 1.75 g/t Au from diamond drilling

BigAl.

Top Man you are. Excellent work.

That's the beauty of GeneDrive kit...

It can detect ALL variants, old and New.

I personally think GDR will soon become the go to company after the huge endorsement with Beckman Coulter deal.

That £5 pounds price target might need to be revised Upwards in coming months in my view.

Perfect. Yes.

MC = Machine

Its crystal clear + when you read RNS again.

"The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument".

The tender got approved very next day by PHE after BC distribution deal with GDR on 28 Jan.

There should be lot more orders to follow through from Europe also. This is just the start. CEO is very upbeat and rightly so. Getting a deal with Beckman Coulter is no walk in the park. Your product has to be really good to attract them.

So yes.....it is a very BIG DEAL.

Revenues for GDR should soar from both Europe and USA in coming months.

28 Jan - GDR distribution deal with Beckman C.
29 Jan - PHE awards contract to Beckman C.

All the dots connect nicely.

28 Jan RNS....

"The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing."